Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cellerant raises $10 million

Stem cell company Cellerant (Palo Alto, Calif.) raised $10

Read the full 99 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE